Medical Devices in Thoughts from the Centre

Deal breaker? Mitigating cyber risk in life sciences M&A

By Nadeem Mohammed, Deloitte MCS Limited

Lock

Imagine the scene: it’s Friday night, eight senior executives at one of the world’s largest companies are sitting around a private dining table at a swanky city restaurant. They’re there to celebrate the closure of a transaction they’ve been toiling over for the past 12 months. You’re the Deal Lead, and you’ve just taken a congratulatory phone call from the Chief Executive – the Board are delighted with the acquisition, which will now be at the heart of the company’s growth strategy. You’ve given blood, sweat and tears on this – you raise a glass towards the table and take a quiet moment to reflect on what is surely a career defining moment.

Continue reading

Posted on 26/07/2019 | 0 Comments

2019 Human Capital Trends: Reinvent with a human focus – the implications for the Life Sciences industry

By Shivani Maitra, Partner, Consulting

Hctrends

This time of year is always a highlight for me as it sees the publication of our annual Global Human Capital Trends report, based on the views of 10,000 survey respondents across 119 countries. This year’s findings reinforce the views of colleagues in the Life Sciences (LS) team, specifically that LS organisations need to rethink the workforce experience, adapt to a more diverse workforce and transform their approach to leadership development.

Continue reading

Posted on 28/06/2019 | 0 Comments

FDA workshop on achieving medical device safety and cybersecurity: Why trustworthiness, transparency, and resilience are critical

By Steven Darroch, Senior Manager, and Nick Sikorski, Manager, Deloitte & Touche LLP

Deloitte-uk-fdi

This week's blog, by Steven Darroch and Nick Sikorski from the US firm, first appeared on the US Center for Health Solutions blog site. The blog follows on from our report Medtech and the Internet of Medical Things: How connected medical devices are transforming health care and a public workshop held by the FDA, and explores the importance of medical device safety and how to mitigate operational, commercial and regulatory risks.

Continue reading

Posted on 26/04/2019 | 0 Comments

Launching innovative biopharma in China: Market access, reimbursement and digital health care

By Mark Steedman, PhD, Manager, Centre for Health Solutions

Rocket

In March, Deloitte colleagues David Xie and Xiaofeng Li published the article Gain the edge in a fast moving market, introducing a series of articles on ‘Launching innovative biopharma in China’. This introductory article was the subject of a previous blog that we published in February.1 This week’s blog explores the findings in the next two articles in the series: A new view on market access and reimbursement, examining innovative alternative reimbursement opportunities in the public and self-pay markets; and A new view on China’s digital health care, evaluating how product launches can target digitally savvy consumers.

Continue reading

Posted on 12/04/2019 | 0 Comments

Addressing the gender imbalance in life sciences today to secure a better tomorrow

By Debi Rhodes, COO & Clients & Industries Lead, Life Sciences & Healthcare

Untitled-11

Today, Friday 8th March marks the annual celebration of International Women’s Day with the theme, Balance for Better. I couldn’t help but question what this day really means to me? How is it important to my future, that of my children, to business and society as a whole, particularly when we consider the Future of Work and the impact of AI and new technologies on the skills and talent that will be needed in tomorrow’s world? Given my tendency for cynicism, I also questioned how the future might impact the issue of gender equality?

Continue reading

Posted on 08/03/2019 | 0 Comments

Voice activated health care: Ready for prime time?

By Mark Steedman, PhD, Research Manager, Centre for Health Solutions

Voice-activated

“Alexa… Volume up!”

Like many children his age, my four-year old nephew loves the Frozen soundtrack, and he recently figured out how to turn up the volume from anywhere in the room without having to be close to the speaker. He uses the voice assistant that’s always on and always listening.

Continue reading

Posted on 18/02/2019 | 0 Comments

The future awakens: how have our life sciences predictions fared in 2018

By Karen Taylor, Director, Centre for Health Solutions

Blog

Last week we provided an update on the three health care predictions from our November 2017 report - The future awakens: Life Sciences and health care predictions 2022. As promised, this week’s blog reviews developments during 2018 on the three predictions that are more life sciences focused and what we might expect to see in 2019.

Continue reading

Posted on 25/01/2019 | 0 Comments

My Take: Highlights from the 2018 FT Conference panel discussion on the potential for a successful life sciences economy in the UK

By John Haughey, Deloitte Industry Leader, Life Sciences & Health Care

Regulatory

Earlier this month I had the pleasure of chairing a panel of life science experts at the Global Financial Times Pharmaceutical and Biotechnology conference.1 The conference brought together some of our industry’s leading minds to discuss the commercial conundrums of disease prevention, the transformational impact of advanced gene and cell therapies and the hope and hype of patient-centricity. The discussion topic for my panel was - ‘Big Bang? Industrial Strategy - Creating a Successful Life Sciences Economy’, and was focused on the UK’s Industrial Strategy and in particular the UK’s sector deal for life sciences.2 In this week’s blog I wanted to share some of my key takeaways from our animated and insightful discussion.

Continue reading

Posted on 30/11/2018 | 0 Comments

A bold future for life sciences regulation: Predictions 2025

By Karen Taylor, Director, Centre for Health Solutions

Deloitte-uk-life-sciences-predictions-2025-banner

Following our 2014 and 2017 Life Science and Health Care Predictions reports, ‘A bold future?’ and ‘The future awakens’, this week we launched our third predictions report, A bold future for Life Sciences Regulation: Predictions 2025. This year’s report presents an unashamedly optimistic view on what Life Sciences regulation might look like in 2025 if both life science companies and regulators were to work more collaboratively, embrace disruptive technologies, and acquire new skills and talent. We argue that this would improve not only the productivity of the regulators and industry but also provide patients with access to the latest medical innovation much sooner. We also imagine through a series of ‘portraits’ how a regulator, company and patient might behave in 2025. This week’s blog provides an overview of the four predictions presented in our future of regulation report and examples of the evidence today that enable us to predict a bold future for life sciences regulation in 2025.

Continue reading

Posted on 08/11/2018 | 0 Comments

Consumers want connected medical devices, but demand for digital experts could put further strain on the talent pool for medtech

By Pedro Arboleda, managing director, Deloitte Consulting LLP

Medical

This week, running from September the 24th to the 26th, our colleagues in the US attended AdvaMed’s annual MedTech Conference. At the conference participants heard about the latest innovations, such as new digital products that incorporate the latest advances in wireless technology and increasingly powerful computing capabilities for generating clinical and economic insights. This week’s blog, by Pedro Arboleda, first appeared on the US Center for health solutions website.1 Below, he discusses his worry that given the rapid advancement in digital technologies the industry might overlook another important change that is occurring in parallel—the ability to attract the specific digital talent needed to deliver on the promise of connected medical devices.

Continue reading

Posted on 28/09/2018 | 0 Comments